ICYMI: electroCore's EUA for COVID
The neuromodulation company has leveraged its original R&D into a treatment for COVID-19.
MedTech Strategist's complimentary Community Blog focuses on the people and the passion behind the global device space. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter BrowseThe neuromodulation company has leveraged its original R&D into a treatment for COVID-19.
At the dawn of the 1970s, the Vietnam War was raging, moon landings were becoming more routine, and Walt Disney World opened its doors. It also marks the debut of NASDAQ, which now has a greater trading volume than any other US stock exchange, including many innovative medtech companies.
The most-read Market Pathways articles of 2020 reflect a year of non-stop emergency decision-making and creative policymaking.
The most-read Market Pathways articles of 2020 reflect a year of non-stop emergency decision-making and creative policymaking.